Rapid approval of generic drugs eyed

The Korea Food and Drug Administration announced on April 5 it has revised the rule concerning the screening of safety and efficacy of drugs, etc. as part of its effort to provide better support for the domestic drug makers to develop generic product over new brands that are subject to re-examination.

The KFDA said that if a person intends to develop a drug which is identical with an item su...